Crucial Factors in Lymphoma Development and Survival Discovered

June 24, 2008

Experiments with new mouse model suggest therapeutic targets

Researchers at National Jewish Medical and Research Center have discovered an important factor in the development of B-cell lymphomas, one of the fastest growing forms of cancer. The B-cell receptor on the surface of B cells can cooperate with the MYC oncogene to accelerate the development of lymphomas. The research team, led by Yosef Refaeli, PhD, Assistant Professor of Pediatrics at National Jewish Medical and Research Center , also showed that disruption of signals from the B-cell receptor can inhibit growth of the tumors. The research is being published in the June 24 issue of the journal, PLos Biology.

"Non-hodgkins lymphomas, about 90 percent of which are B-cell lymphomas, have become 85 percent more prevalent in the past 20 years, the only major form of cancer to experience such growth" said Dr. Refaeli. "Our findings have pointed to the B-cell receptor and its signaling pathways as very promising therapeutic targets for B-cell lymphomas."

Non-Hodgkins lymphoma is a cancer of lymphocytes, immune system cells known as T cells and B cells. About 66,000 new cases of non-Hodgkins lymphoma are diagnosed each year in the United States , and about 19,000 people die of it.

It has long been known that the oncogene MYC plays a crucial role in the development of lymphomas. One unanswered question, however, is whether the B-cell receptor on the surface of B cells, may also play an important role.

When the B-cell receptor binds to molecules on foreign invaders, known as antigens, it sends a signal that causes the B cells to proliferate and produce antibodies. The antibodies bind to the foreign molecules and mark the invaders for destruction. Even if it doesn't bind to an antigen, the B-cell receptor promotes the survival of B cells through an unknown intracellular signal.

Dr. Refaeli and his colleagues at National Jewish and the University of California , San Francisco developed a series of transgenic mice to evaluate the role of the B-cell receptor in B-cell lymphomas. They found that the presence of a functional B-cell receptor increased the development of tumors in mice with a translocated MYC oncogene.

In a series of experiments, Dr. Refaeli demonstrated that the B-cell receptor cooperated with MYC in the development of tumors both in the presence of an antigen and when no antigen was present. When no antigen was present, the mice developed a lymphoma similar to human B-cell lymphocytic leukemia.

When there was an antigen to bind to the B-cell receptor, the mice developed a lymphoma that closely resembled Burkitt's lymphoma, even to the surprising development of primary tumors in one side of the jaw. The researchers actually used an autoantigen, a molecule produced by the mouse itself, in a situation resembling autoimmune disease. Autoimmune disease increases by 50 to 200 times the chance that a person will develop B-cell lymphoma.

In experiments that both confirmed the crucial role of the B-cell receptor and pointed to potential therapies, Dr. Refaeli and his colleagues also were able to prevent and eliminate tumors by treating the mice with immunosuppressants, which block signals from the B-cell receptor. Several trials of various immunosuppressants and another inhibitor of B-cell receptor signaling have recently begun.

"Research into B-cell lymphomas has been hampered by the lack of a good mouse model," said Dr. Refaeli. "The mouse we created gives us a very good, predictive model of B-cell lymphomas, which can be used to explore not only these and related cancers, but also autoimmune disease and basic immunology."

National Jewish Medical and Research Center

---

---

	Living with Lymphoma: A Patient's Guide by Elizabeth M. Adler (Author) When neurobiologist Elizabeth M. Adler was diagnosed with non-Hodgkin lymphoma, she learned everything she could about the disease, both to cope with the emotional stress of being diagnosed and to make sure she made the best possible decisions for her treatment. In Living with Lymphoma, she combines her knowledge of lymphoma—both scientific and personal—with the desire to help other patients come to grips with this complex, and often baffling, disease. Adler thoroughly explains the disease, describing the many different kinds of Hodgkin and non-Hodgkin lymphoma, the wide range of symptoms, and the various treatment options available. Convinced that understanding lymphoma's biological basis will help patients make better treatment decisions, Adler explains basic cell biology and how...
	100 Questions & Answers About Lymphoma, Second Edition by Peter Holman (Author) EMPOWER YOURSELF! Written by oncology experts with over 20 years of experience, 100 Questions and Answers About Lymphoma, Second Edition provides authoritative answers to your questions on lymphoma. Featuring the information you need in one concise, easy-to-read volume, 100 Questions and Answers About Lymphoma, Second Edition is an invaluable resource for newly diagnosed patients, survivors, friends or relatives of either. Now, in its Second Edition, this newly updated text features information on the latest, cutting-edge treatments and medication, Hodgkin s and Non-Hodgkin s lymphoma, natural killer cells, T-cell lymphoma, autoimmune diseases, and much more! Comprehensive, insightful, compact, 100 Questions and Answers About Lymphoma, Second Edition is an essential guide for anyone...
	Johns Hopkins Patients' Guide to Lymphoma by Aditya Bardia (Author), Eric Seifter (Author) Johns Hopkins Patients' Guide to Lymphoma is a concise, easy-to-follow how to guide that puts you on the path to wellness by explaining lymphoma treatment from start to finish. It guides you through the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and performs the task of putting together your plan of care in layman's terms. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your care and treatment.
	Non-Hodgkin Lymphomas by James O. Armitage (Editor), Peter M. Mauch (Editor), Nancy Lee Harris (Editor), Bertrand Coiffier (Editor), Riccardo Dalla-Favera (Editor) Thoroughly updated for its Second Edition, Non-Hodgkin Lymphomas is the definitive textbook on the biology, diagnosis, staging, and treatment of all forms of non-Hodgkin lymphomas. With backgrounds in medical and radiation oncology, molecular biology, and pathology, the editors and contributors provide an international, multidisciplinary approach to the topic. This edition is the first text using the new World Health Organization classification of non-Hodgkin lymphomas. The book offers complete coverage of the most current techniques for diagnosis, staging, and treatment, the approach to specific types of lymphoma, and special problems common to the management of patients with these disorders. A companion Website includes the fully searchable text and downloadable...
	Medifocus Guidebook on: Non-Hodgkin's Lymphoma by Medifocus.com (Author), Elliot Jacob PhD. (Editor) The MediFocus Guidebook on Non-Hodgkin's Lymphoma is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Non-Hodgkin's Lymphoma, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Non-Hodgkin's Lymphoma, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts,...
	My Secret Lymphoma by Hanratty, Philip This book is one patient’s sometimes humorous account of living with and being treated for cancer which he likens to having a mistress. Headaches that began in June of 2009 were not diagnosed as Diffuse Large B-Cell Lymphoma until mid December. Given odds of 50/50 by his oncologist he describes the tests, bone marrow biopsies and treatments which included six cycles of R-CHOP, four spinal infusions with other drugs and, while in remission, three 28-day cycles of Revlimid (AKA Lenalidomide). Starting with the R-CHOP treatments he describes the day to day side effects of chemotherapy and his attempts to deal with them. The remainder of the book describes the aftermath of treatment which lasts much longer than one would normally expect.
	What You Need To Know About: Non- Hodgkin Lymphoma This booklet is about non-Hodgkin lymphoma, a cancer that starts in the immune system. Non-Hodgkin lymphoma is also called NHL. Each year, more than 63,000 Americans learn they have non-Hodgkin lymphoma. This booklet tells about diagnosis, treatment, and supportive care. Learning about the medical care for people with lymphoma can help you take an active part in making choices about your own care.
	Extranodal Lymphomas: Expert Consult - Online and Print, 1e by Judith A. Ferry MD (Author) Extranodal Lymphomas is a practical, easy-to-use guide that helps you accurately diagnose even the most challenging cases. Dr. Judith Ferry and leaders in the field present their expertise to fill the need for a highly-illustrated, authoritative reference that keeps you up to date on histologic, immunophenotypic, genetic, and clinical features, along with risk factors and current nomenclature. This comprehensive resource also features access to the fully searchable text and a downloadable image library online at www.expertconsult.com so you'll have convenient access to everything you need for effective diagnostic decision making.Access the fully searchable text online at www.expertconsult.com, along with a downloadable image bank. See specimens as they appear through the microscope with...
	Skin Lymphoma: The Illustrated Guide by Lorenzo Cerroni (Author), Kevin Gatter (Author), Kerl Helmut (Author) Skin lymphomas are relatively rare and can be easily misdiagnosed as psoriasis or dermatitis. These lymphomas can be fatal. Consequently, those in training in dermatology and pathology need to have a good understanding of the clinical presentations and the pathological correlates of this challenging disease.This updated edition provides:A full-colour illustrated text and atlas that combines pathology with clinical features and treatmentupdated nomenclature according to WHO/EORTC and WHO classificationsImages to expand the diagnostic potentialCases to enhance the scope for teaching and learning
	Understanding Leukemias, Lymphomas and Myelomas by Tariq I. Mughal (Author), Tariq Mughal (Author), John Goldman (Author), John M. Goldman (Author), Sabena T. Mughal (Author), Sabena Mughal (Author) A brand-new edition of the bestselling guide to hematologic malignancies. An international team of contributors come together to present all clinically relevant aspects of leukemias, lymphomas, and myelomas. Using clear terminology, the book discusses salient features, diagnostic procedures, prognosis, and treatments for these cancers. Following on the successful steps of the first edition, this Second Edition covers: various types of leukemias, lymphomas, and myelomas utilizing stem cell transplantation side-effects of various treatments future prospects for leukemia, lymphoma, and myeloma targeted therapies and history of the cancers information and support sources for...